In Vitro Diagnostics Services | Research, Development, Test, and Evaluation
Emerging Infectious Disease
MRIGlobal’s emerging infectious disease services span all stages of the in vitro diagnostic product development process, beginning with research and development through FDA Clearance.
Our infectious disease diagnostics services include development of methods, platforms, and molecular and immunological assays. These services provide a turnkey, outsourcing solution for commercial companies and government agencies seeking to accelerate product development into later clinical verification and validation phases. In addition, MRIGlobal’s CRO offerings include BSL-2+ and BLS-3 biocontainment laboratories, CAP accredited CLIA reference laboratories, and clinical sample acquisition.
Kyle Parker inspects a reagent cartridge prior to loading clinical samples for analysis with a point-of-care device.
MRIGlobal scientists conduct research and development with commercial companies to improve emerging infectious disease diagnostic technologies with the goal of advancing these technologies into verification and validation phases of clinical product development.